Answers are grounded in this paper and cite their sources.
Review reveals rising Barrett's esophagus cases in Japan, focusing on endoscopic resection and surveillance methods.
Background Barrett’s esophagus (BE)-related neoplasia remains less prevalent in Japan than in Western countries; however, its incidence is steadily rising. While multimodal treatment – typically endoscopic resection followed by ablation – is the standard of care, endoscopic resection alone remains the primary treatment strategy in Japan, largely due to the limited availability of ablation devices. With advances in endoscopic techniques, endoscopic submucosal dissection (ESD) has become the mainstay for managing BE-related neoplasia. This review outlines the current Japanese approach, focusing on indications, preoperative assessment, treatment outcomes, and post-resection surveillance practices within the Japanese clinical context. Summary Accurate endoscopic assessment, including the use of magnifying endoscopy with image-enhanced modalities, is central to Japanese practice due to the importance of complete resection of neoplasia in the absence of ablative therapy. While data on BE-related neoplasia remain relatively limited in Japan, several multicenter studies have demonstrated favorable outcomes for ESD in terms of resection quality, safety, and long-term survival, particularly in low-risk patients. However, challenges remain, including the lack of standardized surveillance protocols, limited access to ablation, and considerable heterogeneity in clinical practice across institutions. Surveillance strategies in Japan typically rely on targeted biopsies rather than systematic random biopsies. The establishment of unified clinical pathways and evidence-based strategies will be essential to address the increasing burden of BE-related neoplasia in Japan. Key Messages ・ The incidence of BE and esophageal adenocarcinoma (EAC) is increasing in Japan, although still significantly lower than in Western countries. ・ Unlike the Western standard of combining endoscopic resection with radiofrequency ablation (RFA), Japanese practice relies primarily on ESD as the main curative modality. ・ RFA is not widely available in Japan, leading to a reliance on complete resection and more aggressive endoscopic resection strategies. ・ Surveillance strategies remain inconsistent, largely due to the lower disease prevalence and limited Japan-specific clinical evidence.
No takes yet. Share an insight, caveat, or question.
Shimamura et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: